Related Experiment Videos
Sequential chemo-radiotherapy in non-small cell lung cancer
M Kotas1, J Willner, M Flentje
1Department of Radiation Oncology, University of Wuerzburg, Josef-Schneider-Strasse 11, D-97080, Würzburg, Germany.
Lung Cancer (Amsterdam, Netherlands)
|September 29, 2001
Summary
Sequential chemo-radiotherapy offers a survival benefit for locally advanced non-small cell lung cancer (NSCLC) stage IIIA/IIIB. This treatment approach improves outcomes for patients with this challenging cancer diagnosis.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Locally advanced non-small cell lung cancer (NSCLC) stages IIIA/IIIB constitute 30% of NSCLC cases.
- These stages are associated with a poor prognosis despite current treatment modalities.
Purpose of the Study:
- To review randomized phase III trials evaluating sequential chemo-radiotherapy for locally advanced NSCLC.
- To assess the survival benefit of this treatment strategy.
Main Methods:
- Review of published randomized phase III clinical trials.
- Analysis of survival data from trials comparing sequential chemo-radiotherapy to other treatment regimens.
Main Results:
- Sequential chemo-radiotherapy demonstrated a slight but statistically significant improvement in survival.
- This benefit was observed in patients with locally advanced NSCLC stages IIIA/IIIB.
Conclusions:
- Sequential chemo-radiotherapy is a viable treatment option for locally advanced NSCLC.
- This approach offers a modest survival advantage for patients with stage IIIA/IIIB disease.